Kiropraktisk Klinik Kasper Skov ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 2.9% 3.3% 2.8% 2.6%  
Credit score (0-100)  0 58 53 59 60  
Credit rating  N/A BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 994 1,234 1,236 1,383  
EBITDA  0.0 650 598 642 769  
EBIT  0.0 354 301 345 473  
Pre-tax profit (PTP)  0.0 201.7 169.0 214.3 315.8  
Net earnings  0.0 101.3 126.2 161.8 239.4  
Pre-tax profit without non-rec. items  0.0 202 169 214 316  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 1,210 1,152 1,094 1,035  
Shareholders equity total  0.0 157 236 341 521  
Interest-bearing liabilities  0.0 2,480 2,282 2,190 1,886  
Balance sheet total (assets)  0.0 3,501 3,262 3,252 3,116  

Net Debt  0.0 2,480 2,282 2,190 1,886  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 994 1,234 1,236 1,383  
Gross profit growth  0.0% 0.0% 24.1% 0.2% 11.9%  
Employees  0 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 3,501 3,262 3,252 3,116  
Balance sheet change%  0.0% 0.0% -6.8% -0.3% -4.2%  
Added value  0.0 650.3 597.7 641.6 768.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 3,056 -592 -592 -592  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 35.6% 24.4% 27.9% 34.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 10.1% 8.9% 10.6% 14.8%  
ROI %  0.0% 10.4% 9.2% 11.0% 15.4%  
ROE %  0.0% 64.6% 64.3% 56.1% 55.5%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 4.5% 7.2% 10.5% 16.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 381.4% 381.9% 341.4% 245.3%  
Gearing %  0.0% 1,583.1% 966.4% 642.6% 361.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 12.3% 5.6% 5.9% 7.7%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 0.0 0.0  
Current Ratio  0.0 0.0 0.0 0.0 0.0  
Cash and cash equivalent  0.0 0.0 0.0 0.0 0.0  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -2,578.4 -2,402.8 -2,247.1 -1,995.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 650 598 642 769  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 650 598 642 769  
EBIT / employee  0 354 301 345 473  
Net earnings / employee  0 101 126 162 239